NCT06627010 is a clinical trial of description in Herpes Simplex Meningo Encephalitis, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT06627010?

NCT06627010 is sponsored by Central Hospital, Nancy, France.

What drugs are being tested in NCT06627010?

Interventions in NCT06627010: description.

What condition does NCT06627010 study?

NCT06627010 studies Herpes Simplex Meningo Encephalitis.

Is NCT06627010 still recruiting?

NCT06627010 is currently status unknown. Last updated 4 October 2024.

Last reviewed 2024-10-04 · How we verify

NCT06627010

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Herpes Simplex Meningo Encephalitis Recurrence

Status unknown Last updated 4 October 2024

What this trial tests

trial testing description in Herpes Simplex Meningo Encephalitis in 30 participants. Status unknown.

Timeline

1 January 2012

Primary endpoint
1 January 2012

28 January 2025

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 January 2012
Primary completion	1 January 2012
Estimated completion	28 January 2025
Sites	1 location across France

Drugs / interventions tested

description

Conditions studied

Herpes Simplex Meningo Encephalitis — all drugs for Herpes Simplex Meningo Encephalitis →

Sponsor

Central Hospital, Nancy, France

Who can join

Eligibility, any sex, with Herpes Simplex Meningo Encephalitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

study of risk factors and prognosis of herpes simplex encephalitis recurrence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of description

Trials testing the same drug.

NCT06032312 — Metabolically Healthy Obese · unknown

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06627010 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 4 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing